Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CDK12 Stable Cell Line

    [CAT#: S01YF-1123-KX178]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1060 Magic™ Human CDK12wt/CycK in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    CDK12
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    HCT116; CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cardiovascular Research; Cancer Research; Reproductive Research
    Related Diseases
    Lung Cancer Susceptibility 3 and Congenital Heart Defects, Dysmorphic Facial Features, And Intellectual Developmental Disorder. Among its related pathways are Gene expression (Transcription) and Formation of HIV elongation complex in the absence of HIV Tat.
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Cyclin Dependent Kinase 12 Protein is encoded by CDK12. Lung cancer susceptibility, congenital heart defects, dysmorphic facial features, and intellectual developmental disorder are diseases linked to CDK12. Gene expression (transcription) and the formation of the HIV elongation complex in the absence of HIV Tat are two of its associated mechanisms. Cyclin-dependent kinase that plays a crucial role in controlling transcription elongation by phosphorylating the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A). controls the expression of genes necessary for DNA repair and is necessary to keep the genome stable. necessary for RNA splicing; phosphorylation of SRSF1/SF2 may be the mechanism. involved in controlling the activity of MAP kinase, which may impact how the body reacts to estrogen inhibitors. The customized CDK12 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Jason

    The human CDK12 cell line was an indispensable tool in my research. The cell line's stability and reproducibility were outstanding, allowing for reliable results across multiple experiments. Mar 18 2023

    chat Verified Customer

    chat Cynthia

    The CDK12 cell line is of high quality and performs exceptionally well in my experiments. Dec 29 2022

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 CDK12/13 inhibition results in selective cytotoxicity in NB cells and affects transcription elongation.

    Human NB cells treated with THZ531 at escalating doses for 72 hours showed dose-response curves. Included as well were Kelly E9R cells, which exhibit a homozygous mutation at the Cys1039 THZ531-binding region in CDK1220.

    Ref: Krajewska, Malgorzata, et al. "CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation." Nature communications 10.1 (2019): 1757.

    Pubmed: 30988284

    DOI: 10.1038/s41467-019-09703-y

    Research Highlights

    As a member of the cyclin-dependent kinase (CDK) family of serine/threonine protein kinases, cyclin-dependent kinase 12 (CDK12) controls transcriptional and post-transcriptional processes, which in turn affects a variety of cellular functions.
    Lui, Goldie YL, Carla Grandori, and Christopher J. Kemp. "CDK12: an emerging therapeutic target for cancer." Journal of clinical pathology 71.11 (2018): 957-962.
    Pubmed: 30104286   DOI: 10.1136/jclinpath-2018-205356

    A growing therapeutic target, cyclin-dependent kinase 12 (CDK12) controls the transcription of DNA-damage response (DDR) genes.
    Jiang, Baishan, et al. "Discovery and resistance mechanism of a selective CDK12 degrader." Nature chemical biology 17.6 (2021): 675-683.
    Pubmed: 33753926   DOI: 10.1038/s41589-021-00765-y

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare